| Literature DB >> 19003520 |
Abstract
The growth regulating factor CTGF/CCN-2 is an integral factor in growth and development, connective tissue maintenance, wound repair and cell cycle regulation. It has recently been reported that CTGF/CCN-2 is involved in very early development having been detected in early notochord formation in zebrafish using CTGF/CCN-2 promoter-driven green fluorescent protein (GFP) plasmids. In these studies fluorescence was detected early in the developing embryos, a finding of considerable significance in that CTGF/CCN-2 deficient mutant mice die early after birth due to severe cartilage and skeletal dysplasia and respiratory failure. Such findings confirm the importance of CTGF/CCN-2 in development and of the necessary and sufficient role of this molecule in formation of the skeleton, extracellular matrix and chondrogenesis. Of particular relevance to the relationship between the notochordal cell and CTGF/CCN-2 there is a remarkable sub-species of canine, the 'non-chondrodystrophic' canine that is protected from developing degenerative disc disease (DDD). These animals are unique in that they preserve the population of notochordal cells within their disc nucleus (NP) and these cells secrete CTGF/CCN-2. We have detected CTGF/CCN-2 within conditioned medium developed from the notochordal cells of these animals (NCCM) and used this conditioned medium to demonstrate robustly increased proteoglycan production. The addition of recombinant human CTGF/CCN-2 to totally serum-free media containing cultures of bovine NP cells replicated the robustly increased aggrecan gene expression found with NCCM alone strongly suggesting the importance of the effect of CTGF/CCN-2 in notochordal cell biology within the disc nucleus of non-chondrodystrophic canines. The chondrodystrophic canine, another sub-species on the other hand are almost totally devoid of notochordal cells and they develop DDD profoundly and early. These two sub-species of canine reflect a naturally occurring animal model that is an excellent example of differential notochordal cell survival and possible associated developmental differences in extracellular maintenance.Entities:
Year: 2008 PMID: 19003520 PMCID: PMC2648046 DOI: 10.1007/s12079-008-0031-5
Source DB: PubMed Journal: J Cell Commun Signal ISSN: 1873-9601 Impact factor: 5.782
Fig. 1Aggrecan gene expression (normalized to HPRT) for disc-derived chondrocytes. Chondrocytes were cultured for 24 h with either, DMEM, 50 ng/ml, 100 ng/ml, 200 ng/ml rCTGF and NCCM. Amplicons were generated from the reverse transcription and subsequent PCR using aggrecan specific primers of 1 µg total RNA harvested from treated chondrocytes (Trizol). The above results reflect mean gene expression ratios of between 5 and 9 separate experiments all from at least three separate sources of chondrocytes and notochord cells. DMEM and CTGF 50 were repeated three times, CTGF 100 and 200 were repeated eight times, and NCCM was repeated nine times. (This figure from Erwin et al. 2006)
Fig. 210 μg Notochordal cell lysates run in parallel using rabbit anti-CTGF Western Blot (black arrowhead) lanes 1–2. Control lanes were murine β-cells, lanes 3–4
Fig. 3Schematic depicting notochordal cell interaction with nucleus pulposus cells. The notochordal cell secretes a pro-form of CCN2 that is likely activated within the cytoplasm to the active form. CCN2 acts in a paracrine fashion upon nucleus pulposus cells. The possible role of TGF-β within this notochordal cell/nucleus pulposus cell milieu is a question at the present. CCN2 is known to be a downstream effector molecule of TGB-β signaling-however the specific role of TGF-β within this pathway has not yet been tested. Notochordal cells secrete a unique form of aggrecan themselves (depicted as notochordal cell secreted increased proteoglycan synthesis). Also, soluble factors secreted by notochordal cells activate nucleus pulposus cells to increase their proteoglycan production (indicated as increased proteoglycan synthesis by nucleus pulposus cells in red)